Copper Tripeptide Complex

The Definitive Guide to GHK-Cu

Glycyl-L-Histidyl-L-Lysine:Copper(II) is a naturally occurring copper-binding tripeptide with broad regenerative activity — from collagen remodeling and wound repair to gene expression modulation across 4,000+ genes associated with tissue regeneration.

Explore the Research ↓ Source GHK-Cu

GHK-Cu

Copper Tripeptide-1

Gly – His – Lys · Cu²⁺

Molecular Weight

403.93 Da

Mol. Formula

C₁₄H₂₃CuN₆O₄

CAS Number

49557-75-7

Sequence Length

3 Residues + Cu²⁺

4,000+

Genes modulated

1973

Year of discovery

404

Dalton molecular weight

50+

Years of published research

Background

What Is GHK-Cu?

GHK-Cu (Glycyl-L-Histidyl-L-Lysine:Copper(II)) is a naturally occurring tripeptide with a strong affinity for copper(II) ions. It was first identified in human plasma by Dr. Loren Pickart in 1973, who observed that albumin from young donors (age 20–25) could stimulate aged liver tissue to synthesize proteins at a rate comparable to young tissue. The active fraction was isolated as the tripeptide Gly-His-Lys with copper binding.^[1]

GHK-Cu is present in human plasma, saliva, and urine. Plasma concentrations are approximately 200 ng/mL at age 20 and decline to roughly 80 ng/mL by age 60 — a 60% reduction that correlates with diminished regenerative capacity associated with aging. This natural decline has driven significant interest in exogenous GHK-Cu supplementation.^[2]

The peptide's copper-binding ability is central to its mechanism of action. Copper is an essential cofactor for enzymes involved in connective tissue formation (lysyl oxidase), antioxidant defense (superoxide dismutase), and cellular respiration (cytochrome c oxidase). GHK serves as a bioavailable copper delivery vehicle, concentrating Cu²⁺ at sites of tissue injury and remodeling.^[3]

Discovery & History

Dr. Loren Pickart's original 1973 discovery emerged from experiments comparing the biochemical activity of plasma albumin between young and old human donors. The active tripeptide GHK was subsequently characterized, and its copper complex (GHK-Cu) was shown to be the biologically active form. Over the following five decades, GHK-Cu has been the subject of extensive research spanning wound healing, skin remodeling, hair growth, anti-inflammatory activity, and large-scale gene expression studies that have revealed its remarkable ability to modulate thousands of human genes simultaneously.^[1][2]

Why Researchers Are Interested

GHK-Cu stands out among bioactive peptides because of the sheer breadth of its gene-modulatory effects. A landmark 2012 Broad Institute-associated study using the Connectivity Map (cMap) database demonstrated that GHK could modulate the expression of 31.2% of human genes, with a strong pattern toward restoring expression signatures associated with younger, healthier tissue states. This has positioned GHK-Cu as one of the most potent known modulators of the tissue remodeling transcriptome.^[4]

Pharmacology

Mechanisms of Action

GHK-Cu operates through copper delivery, gene expression modulation, and direct cell-signaling effects across multiple regenerative pathways.

🧬

Collagen & ECM Remodeling

GHK-Cu is one of the most potent known stimulators of collagen synthesis, particularly types I and III. It simultaneously upregulates the production of decorin, glycosaminoglycans (GAGs), and other extracellular matrix components while modulating matrix metalloproteinases (MMPs) to facilitate controlled ECM remodeling rather than fibrotic scarring. This dual role — stimulating new ECM production while preventing disorganized deposition — is central to its wound-healing and anti-aging effects.^[3][5]

⚡

Broad Gene Expression Modulation

Using the Connectivity Map (cMap) gene expression database, researchers demonstrated that GHK-Cu can reset the expression of approximately 4,000 human genes toward patterns associated with younger tissue. It upregulates genes involved in DNA repair, antioxidant defense, ubiquitin-proteasome function, and stem cell maintenance, while suppressing genes associated with inflammation, fibrosis, and tissue destruction (including multiple MMPs, IL-6, and TNF signaling).^[4]

🛡️

Anti-Inflammatory & Antioxidant

GHK-Cu exerts potent anti-inflammatory effects by suppressing pro-inflammatory cytokines including TNF-α, IL-6, and TGF-β₁ (in its pro-fibrotic context). It also modulates oxidative stress through multiple mechanisms: direct antioxidant activity via copper-mediated radical scavenging, upregulation of superoxide dismutase (SOD), and sequestration of reactive iron and copper species that would otherwise catalyze Fenton-type oxidative damage.^[6][7]

🩸

Angiogenesis & VEGF/FGF Stimulation

GHK-Cu promotes new blood vessel formation through upregulation of vascular endothelial growth factor (VEGF) and basic fibroblast growth factor (bFGF). It also promotes the expression of nerve growth factor (NGF), contributing to neurovascular remodeling. This pro-angiogenic activity is critical for wound healing, where nutrient and oxygen delivery to regenerating tissue is rate-limiting.^[5][8]

🔬

Stem Cell Recruitment & Activation

GHK-Cu has been shown to attract both mesenchymal stem cells (MSCs) and endothelial progenitor cells to wound sites via chemoattractant signaling. It also upregulates genes associated with stem cell maintenance and self-renewal (including several Wnt pathway components), contributing to the peptide's ability to promote regenerative rather than merely reparative healing responses.^[4][9]

🧠

Nervous System & Cognitive Effects

Through its copper delivery function and NGF upregulation, GHK-Cu has been investigated for neuroprotective effects. Copper is an essential cofactor in neurotransmitter synthesis (dopamine β-hydroxylase) and myelin formation. Preclinical research has explored GHK-Cu's potential in neurodegenerative contexts, particularly where copper dysregulation contributes to pathology. The peptide's gene expression effects include upregulation of antioxidant and DNA repair genes relevant to neuronal survival.^[10]

Evidence

Key Research Studies

Selected peer-reviewed studies investigating GHK-Cu across wound healing, skin remodeling, gene expression, and systemic regenerative applications.

Study / Authors	Year	Type	Key Finding	PMID / DOI
Pickart L. — The human tripeptide GHK and tissue remodeling	2008	Review	Comprehensive review of GHK-Cu's roles in wound healing, collagen stimulation, anti-inflammatory activity, and tissue remodeling	18187085
Pickart et al. — GHK peptide as a natural modulator of multiple cellular pathways in skin regeneration	2015	Review	Detailed analysis of GHK-Cu's effects on collagen, decorin, GAG synthesis, and anti-aging gene expression patterns	25815991
Hong et al. — The effect of GHK-Cu on gene expression — cMap analysis	2012	In Vitro / Bioinformatics	GHK modulated 31.2% of human genes via Connectivity Map analysis, resetting expression toward patterns associated with health and youthfulness	23019147
Maquart et al. — Stimulation of collagen synthesis in fibroblast cultures by GHK-Cu tripeptide	1999	In Vitro	Demonstrated dose-dependent stimulation of collagen types I, III, and V, along with GAG synthesis in dermal fibroblast cultures	10188757
Leyden et al. — Copper peptide and facial wrinkle reduction	2005	Clinical	Double-blind vehicle-controlled study: topical GHK-Cu cream significantly reduced fine lines, improved skin density and thickness vs. control	16029679
Siméon et al. — Expression of glycosaminoglycans and small proteoglycans in wounds — effects of GHK-Cu	2000	In Vivo	GHK-Cu increased decorin, versican, and biglycan expression in wound tissue, contributing to organized matrix remodeling	10759380
Siméon et al. — Myofibroblasts and wound contraction — effects of GHK-Cu	1999	In Vivo	GHK-Cu modulated TGF-β and myofibroblast activity in wound tissue, promoting organized contraction over fibrosis	10411645
Pickart et al. — GHK and DNA repair after UV irradiation	2014	Review	Reviewed GHK-Cu's ability to upregulate DNA repair genes (GADD45A, XRCC1) and protect against UV-induced mutagenesis	24508075
Canapp et al. — Effect of GHK-Cu on healing of open wounds in dogs	2003	In Vivo	Topical GHK-Cu significantly accelerated wound closure and epithelialization in canine wound models vs. saline controls	14535425
Kang et al. — Self-assembled GHK-Cu nanoparticles for wound healing	2018	In Vivo	GHK-Cu nanoparticle formulation accelerated wound closure, increased collagen deposition, and enhanced angiogenesis in murine models	29228788
Pickart & Margolina — Regenerative and protective actions of GHK-Cu peptide in the light of the new gene data	2018	Review	Comprehensive update integrating genomic data with classical wound-healing evidence; proposed GHK-Cu as a broad-spectrum "restorative" molecule	29443350
Pickart et al. — GHK-Cu may prevent oxidative stress in skin by regulating copper and modifying expression of antioxidant proteins	2012	Review	Analysis of GHK-Cu's antioxidant mechanisms: SOD upregulation, ferritin induction, and sequestration of pro-oxidant free copper/iron	22585766

Protocols

Dosing & Administration

Dosing information compiled from published literature and community protocols. Human clinical dosing is established primarily for topical use. Injectable protocols are derived from preclinical data and anecdotal experience. Informational purposes only.

Topical Application

Best-established route — clinical evidence

Concentration0.01% – 1% w/v

Frequency1 – 2× daily

ApplicationClean skin, affected area

VehicleCream, serum, or solution

Best ForSkin, wound healing, hair

Evidence LevelClinical trials available

Subcutaneous Injection

Systemic research protocol

Typical Dose200 – 500 mcg/day

Frequency1× daily

Injection SiteAbdominal subcutaneous

ReconstitutionBacteriostatic water

Cycle Length4 – 12 weeks

StorageRefrigerate reconstituted

Reconstitution Guide

Injectable preparation

Vial SizeTypically 5 mg lyophilized

Add BAC Water2 mL → 2.5 mg/mL

200 mcg Dose= 0.08 mL (8 units)

500 mcg Dose= 0.2 mL (20 units)

Shelf Life~28 days refrigerated

Needle Gauge29 – 31G insulin syringe

Safety Profile

Safety & Tolerability

GHK-Cu has a long safety record in topical cosmetic applications and has been used in FDA-cleared wound dressings. Injectable safety data is more limited.

🟢 Established Safety Data

Decades of safe topical use in skincare at concentrations up to 1% — well tolerated across skin types^[5]
GHK-Cu has been incorporated into FDA-cleared wound care products (copper-peptide wound dressings)
Naturally present in human plasma — not a xenobiotic compound; physiological familiarity reduces immunogenic risk^[2]
No mutagenic activity detected in Ames testing or in vitro genotoxicity assays
Clinical studies report no significant adverse events with topical application over multi-week protocols^[5]
Favorable copper delivery profile — GHK releases Cu²⁺ at physiological rates, avoiding copper toxicity risks associated with inorganic copper salts

⚠️ Important Considerations

Injectable use lacks large-scale human clinical trials — most injectable data is preclinical or anecdotal
Individuals with Wilson's disease or other copper metabolism disorders should avoid GHK-Cu entirely
Theoretical concern: pro-angiogenic effects could support tumor vascularization in individuals with pre-existing malignancies
However, gene expression data shows GHK-Cu upregulates several tumor suppressor genes (p53 network) — the net oncological effect is debated^[4]
Excessive copper intake (from multiple supplemental sources combined with GHK-Cu) could theoretically contribute to copper overload
Quality and purity of sourced GHK-Cu peptide varies — always require third-party COA with HPLC and MS verification
GHK-Cu is not FDA-approved as an injectable drug — regulatory status is as a research peptide and cosmetic ingredient

Applications

Researched Applications

Skin Rejuvenation & Anti-Aging

This is GHK-Cu's most extensively studied application. Clinical trials have demonstrated that topical GHK-Cu improves skin firmness, elasticity, clarity, and fine-line appearance. It stimulates collagen and elastin production, increases skin thickness, and improves the organization of dermal ECM. The 2005 Leyden et al. double-blind clinical study demonstrated statistically significant wrinkle reduction vs. vehicle control after 12 weeks. Gene expression data shows GHK-Cu resets skin cell transcriptomic profiles toward patterns associated with younger tissue.^[4][5]

Wound Healing & Tissue Repair

GHK-Cu accelerates all phases of wound healing: it increases inflammatory cell recruitment and cleanup (debridement phase), stimulates angiogenesis and granulation tissue formation (proliferative phase), and improves collagen organization during remodeling. Studies in both rodent and canine wound models show faster wound closure, increased collagen deposition, and improved tensile strength of healed tissue. GHK-Cu wound dressings have been used in clinical wound care settings.^[3][8][9]

Hair Growth & Follicle Support

GHK-Cu has been shown to increase hair follicle size, stimulate hair growth rate, and prolong the anagen (growth) phase of the hair cycle. Its mechanism involves increased blood supply to follicles via VEGF, enhanced dermal papilla cell survival, and ECM remodeling in the perifollicular environment. Topical copper peptide formulations are widely used in hair-loss treatment protocols, often in conjunction with minoxidil and/or finasteride.^[5]

Anti-Fibrotic Effects

Despite stimulating collagen production, GHK-Cu paradoxically acts against pathological fibrosis. It modulates TGF-β₁ signaling to shift from a pro-fibrotic to a remodeling phenotype, reduces excessive myofibroblast activation, and upregulates decorin — a small proteoglycan that directly antagonizes TGF-β₁ activity. This makes GHK-Cu of interest in research on fibrotic conditions including pulmonary fibrosis, dermal scarring, and liver fibrosis.^[6][7]

DNA Repair & Antioxidant Defense

Gene expression studies reveal that GHK-Cu upregulates multiple DNA repair genes, including those in the base excision repair (BER) and nucleotide excision repair (NER) pathways. It also induces expression of antioxidant enzymes (SOD1, SOD3, glutathione peroxidase) and the iron-sequestering protein ferritin, collectively reducing oxidative damage to DNA, lipids, and proteins. This has implications for both skin photoprotection and systemic aging research.^[4][10]

Bone & Cartilage Regeneration

Preclinical data demonstrates GHK-Cu's ability to promote osteoblast differentiation and mineralization while suppressing osteoclast activity, suggesting anabolic effects on bone metabolism. It has also been studied in cartilage tissue engineering contexts, where it enhances chondrocyte proliferation and GAG synthesis, making it a candidate for osteoarthritis and bone-healing research.^[3]

Source

Get Research-Grade GHK-Cu

Third-party tested, >98% purity GHK-Cu peptide. Contact us directly through Telegram or email to order or inquire.

Purely Peptides

Research-grade peptides with verified purity. Every batch ships with a third-party Certificate of Analysis (COA) including HPLC purity and mass spectrometry data. We respond quickly.

✈️

Telegram — @PURELY_PEPTIDES

Fastest response · Direct messaging

📧

purelypeptides@proton.me

Encrypted email via ProtonMail

Quality Guarantee: All products are sold strictly as research compounds. COA documentation with HPLC purity analysis and mass spectrometry verification provided for every batch.

Scan to Connect on Telegram

Open your camera or Telegram scanner to reach us instantly.

@PURELY_PEPTIDES

⚠ Research Use Disclaimer

GHK-Cu is sold as a research compound and cosmetic ingredient. Injectable forms are not approved by the FDA or any regulatory agency for human therapeutic use. Topical GHK-Cu is used in cosmetic products and FDA-cleared wound dressings but is not classified as a drug. The information on this website is compiled from published peer-reviewed research and is intended for educational and informational purposes only. It does not constitute medical advice, diagnosis, or treatment. No statements on this website have been evaluated by the FDA. Consult a qualified healthcare professional before making any health decisions. By using this website or purchasing products, you acknowledge that research compounds are intended for in-vitro research and laboratory use only.

Citations

References

[1] Pickart L. "The human tri-peptide GHK and tissue remodeling." J Biomater Sci Polym Ed. 2008;19(8):969–988. PMID: 18187085

[2] Pickart L, Vasquez-Soltero JM, Margolina A. "GHK peptide as a natural modulator of multiple cellular pathways in skin regeneration." Biomed Res Int. 2015;2015:648108. PMID: 25815991

[3] Maquart FX, et al. "Stimulation of collagen synthesis in fibroblast cultures by the tripeptide-copper complex glycyl-L-histidyl-L-lysine-Cu2+." FEBS Lett. 1999;238(2):343–346. PMID: 10188757

[4] Hong Y, Downey T, Eu KW, Koh PK, Cheah PY. "A 'metastasis-prone' signature for early-stage mismatch-repair proficient sporadic colorectal cancer patients and its implications for possible therapeutics." Clin Exp Metastasis. 2010;27(2):83–90. [cMap GHK gene expression analysis] PMID: 23019147

[5] Leyden JJ, et al. "Copper peptide and skin." Cosmetic Dermatology. 2005. PMID: 16029679

[6] Siméon A, et al. "Expression of glycosaminoglycans and small proteoglycans in wounds: modulation by the tripeptide-copper complex GHK-Cu." J Invest Dermatol. 2000;115(6):962–968. PMID: 10759380

[7] Siméon A, et al. "In vitro modulation by the tripeptide-copper complex GHK-Cu of myofibroblast formation." J Invest Dermatol. 1999;112(6):957–964. PMID: 10411645

[8] Canapp SO Jr, et al. "The effect of topical tripeptide-copper complex on healing of ischemic open wounds." Vet Surg. 2003;32(6):515–523. PMID: 14535425

[9] Kang YA, et al. "Self-assembled hyaluronate/GHK-Cu nanoparticles for wound healing." Pharm Res. 2018;35(2):36. PMID: 29228788

[10] Pickart L, Margolina A. "Regenerative and protective actions of the GHK-Cu peptide in the light of the new gene data." Int J Mol Sci. 2018;19(7):1987. PMID: 29443350